ORAL COMPOSITION AND METHODS OF IMMUNOTHERAPY Russian patent published in 2020 - IPC A61K39/385 A61P35/00 

Abstract RU 2719586 C2

FIELD: medicine.

SUBSTANCE: group of inventions refers to an oral composition for treating cancer containing a metal associated with at least one tumor antigen and at least one alloantigen or fragments thereof, wherein said metal is magnesium, calcium or strontium or a combination thereof, and wherein said alloantigen is selected from albumin, serums mixed from peripheral blood of healthy individuals, or serums mixed from peripheral blood of the patients with diagnosed cancer. Group of inventions also relates to a method of treating cancer in a subject in need thereof, comprising orally administering to a subject a therapeutically effective dose of said composition; a method for inducing an anti-inflammatory immune reaction in an individual comprising oral administration of a therapeutically effective dose of the composition to a subject, wherein the composition contains a tumor antigen and an alloantigen bound to a metal.

EFFECT: group of inventions provides treating cancer and inducing an anti-inflammatory immune reaction in a subject.

31 cl, 2 dwg, 4 tbl, 13 ex

Similar patents RU2719586C2

Title Year Author Number
CDH3-PEPTIDE AND DRUG PREPARATION CONTAINING IT 2008
  • Nisimura Jasukharu
  • Imai Katsunori
  • Tsunoda Takuja
  • Nakamura Jusuke
RU2483078C2
T-CELLS WITH TRANSDUCED ANTIGEN APPLIED AS ANTIGEN DELIVERY SYSTEMS 2003
  • Traversari Katja
  • Bordin'On Klaudio
RU2330884C2
METHODS AND COMPOSITIONS FOR TREATING TUMORS 2017
  • Griscelli Frank
  • Turhan Ali
  • Bennaceur-Griscelli Annelise
RU2741786C2
COMBINATION OF RECOMBINANT MICROBACTERIUM AND BIOLOGICALLY ACTIVE AGENT AS VACCINE 2005
  • Lejfer Al'Brekht
  • Ajzele Bernd
  • Grode Leander
RU2495677C2
COMBINATION OF AN IMMUNE CHECKPOINT MODULATOR AND A COMPLEX CONTAINING A CELL-PENETRATING PEPTIDE, A CARGO MOLECULE, AND A TLR PEPTIDE AGONIST, FOR APPLICATION IN MEDICINE 2017
  • Derouazi Madiha
  • Belnoue Elodie
RU2769314C1
METHODS OF TREATING CANCER USING ACTIVATED T-CELLS 2016
  • Tang, Longqing
  • Tao, Ran
  • Liu, Junyun
  • Wu, Dongyun
  • Han, Yanyan
  • Li, Jin
  • Zhou, Xiangjun
RU2729362C2
MYBL2 EPITOPE PEPTIDES AND VACCINES CONTAINING THEM 2009
  • Tsunoda Takuja
  • Okhsava Rjudzi
RU2496787C2
METHODS FOR INCREASING EFFECTIVENESS OF ANTITUMOUR IMMUNE RESPONSE 2015
  • Khleif, Samir
RU2689162C2
IMMUNOGENIC PEPTIDES FOR APPLICATION FOR PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES, THE IMMUNE RESPONSES TO ALLOGENEIC FACTORS, ALLERGIC DISEASES, TUMOUR, TRANSPLANT REJECTION AND IMMUNE RESPONSES AGAINST VIRAL VECTORS USED FOR GENETIC THERAPY OR GENETIC VACCINATION 2011
  • Sen-Remi Zhan-Mari
RU2615460C2
CDCA1 EPITOPE PEPTIDES AND VACCINES CONTAINING SAME 2009
  • Tsunoda Takuja
  • Okhsava Rjudzi
  • Josimura Satiko
RU2502740C2

RU 2 719 586 C2

Authors

Burinbajar Aldar

Dzhiratkhitikal Vichaj

Dates

2020-04-21Published

2015-06-15Filed